London’s AI-driven drug discovery company BenevolentAI begins trading on Euronext Amsterdam through SPAC merger
Image credit: BenevolentAIBenevolentAI, a London-based clinical-stage AI-powered drug discovery firm, introduced on Monday that it has began buying and selling on Euronext Amsterdam underneath the ticker image BAI. The announcement comes ...